-
Featured
Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
In this Q&A, Lorenzo Berra, MD, and Charles Hardin, MD, PhD, of Massachusetts General Hospital explain the link between acute respiratory distress syndrome (ARDS) and share insight into upcoming research on antiviral treatment approaches.
-
Histopathology of COVID-19 Is Typical of Acute Respiratory Distress Syndrome
By reviewing autopsy and biopsy studies, Massachusetts General Hospital researchers have shown that COVID-19 manifests principally as diffuse alveolar damage, the histopathologic pattern typically associated with acute respiratory distress syndrome.
-
Preprint Data from RECOVERY Trial Show Mortality Benefit of Dexamethasone in COVID-19
The new standard of care is to consider dexamethasone for COVID-19 patients who are on oxygen or have hypoxemic respiratory failure.
-
ARDS Related to COVID-19 Expected to Cause Increase of Pulmonary Fibrosis
Within the next year, physicians can expect to see increased numbers of patients with fibrotic lung disease that has developed as a complication of acute respiratory distress syndrome related to COVID-19.
-
Right Ventricular Dysfunction May Prove to Be Common with COVID-19
Massachusetts General Hospital clinicians note that, to date, there is no convincing evidence that right ventricular failure in patients with COVID-19 has any novel features.
-
No Evidence to Support Novel Mechanism of Hypoxemia in COVID-19
According to Massachusetts General Hospital clinicians, observations of hypoxemia in COVID-19 are entirely consistent with known mechanisms and do not require the invocation of novel processes specific to SARS-CoV-2.
Learn about the Division of Pulmonary and Critical Care Medicine
ARDS contributors
-
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
David M. Dudzinski, MD
Intensive Care Cardiologist, Massachusetts General Hospital, Director, Cardiac Intensive Care Unit, Associate Editor, Case Records of the MGH
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Case Series: Inhaled Nitric Oxide for Pregnant Patients with Severe or Critical COVID-19
